Ephrilime 7.5 mg/2 mg Syrup
By Ephrilime
Rx
100ml Syrup in a Bottle

Composition
Chlorpheniramine Maleate(7.5mg) + Codeine(2mg)

Manufacturer - Union Drug
Union Drug Company Ltd, No 182, Roy Bahadur Road, Behala, Kolkata-700034, West Bengal, India

Expires on or after
August, 2025

liver
When using Ephrilime 7.5 mg/2 mg Syrup, caution is advised for patients with liver disease. It may be necessary to adjust the dosage of Ephrilime 7.5 mg/2 mg Syrup in such cases. It is important to consult your doctor regarding the use of this medication to ensure the best possible outcome for your liver health.

kidney
Ephrilime 7.5 mg/2 mg Syrup is likely safe for patients with kidney disease, and dose adjustment may not be necessary. However, it may lead to increased drowsiness in those with end stage kidney disease. Please consult your doctor.

alcohol
When taking Ephrilime 7.5 mg/2 mg Syrup, be aware that alcohol can increase drowsiness.

driving
When taking Ephrilime 7.5 mg/2 mg Syrup, be cautious while driving due to possible side effects like dizziness, blurred vision, and impaired thinking ability. These effects may impact your driving skills.

pregnancy
Ephrilime 7.5 mg/2 mg Syrup may be harmful during pregnancy based on animal studies, with limited human data available. Consult your doctor as they will assess the benefits and risks before prescribing it to you.

breastfeeding
Ephrilime 7.5 mg/2 mg Syrup is likely safe for breastfeeding based on limited data; however, it may cause sleepiness or other effects in the baby with higher doses or extended use.
Habit Forming | ~ |
Chemical Class | - |
Therapeutic Class | - |
Action Class | - |
₹87
Inclusive of all taxes
Content verified by

Dr. Monie Riju Simon
MBBS - General Medicine
Last update on 11-Feb-2025